BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 32024388)

  • 1. Fluorescence in situ hybridisation combined with CD138 immunomagnetic sorting is effective to identify cytogenetic abnormalities which play significant prognostic roles in Chinese AL amyloidosis patients.
    Liu Y; Lai Y; Ma L; Wen L; Duan W; Wang F; Kang Y; Chen H; Chen Y; Gao L; Huang X; Lu J
    Amyloid; 2020 Sep; 27(3):208-209. PubMed ID: 32024388
    [No Abstract]   [Full Text] [Related]  

  • 2. AL amyloidosis: The effect of fluorescent in situ hybridization abnormalities on organ involvement and survival.
    Ozga M; Zhao Q; Benson D; Elder P; Williams N; Bumma N; Rosko A; Chaudhry M; Khan A; Devarakonda S; Kahwash R; Vallakati A; Campbell C; Parikh SV; Almaani S; Prosek J; Bittengle J; Pfund K; LoRusso S; Freimer M; Redder E; Efebera Y; Sharma N
    Cancer Med; 2021 Feb; 10(3):965-973. PubMed ID: 33347707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Application of CD138 Immunomagnetic Bead Sorting Combined with Fluorescence in Situ Hybridization in Multiple Myeloma].
    Li QZ; Tan K; Liu YX; Huang H; Zhang Y; Chen HM; Chen ZZ; Zhu ZW; Yang BH; Hu GY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Oct; 30(5):1496-1500. PubMed ID: 36208255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presence of fluorescent in situ hybridization abnormalities is associated with plasma cell burden in light chain amyloidosis.
    Hammons L; Brazauskas R; Pasquini M; Hamadani M; Hari P; D'Souza A
    Hematol Oncol Stem Cell Ther; 2018 Jun; 11(2):105-111. PubMed ID: 28830801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Six-2 glomerular expression for the prediction of renal outcome in systemic amyloidosis.
    Rodas LM; Garcia-Herrera A; Ramirez Bajo M; Fernandez-Larrea C; Cibeira MT; Blasco M; Rosiñol L; Solé M; Blade J; Campistol JM; Quintana LF
    Amyloid; 2019; 26(sup1):97-98. PubMed ID: 31343337
    [No Abstract]   [Full Text] [Related]  

  • 6. AL amyloidosis with a localized B cell neoplasia.
    Stuhlmann-Laeisz C; Schönland SO; Hegenbart U; Oschlies I; Baumgart JV; Krüger S; Röcken C
    Virchows Arch; 2019 Mar; 474(3):353-363. PubMed ID: 30680453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Burden of cytogenetically abnormal plasma cells in light chain amyloidosis and their prognostic relevance.
    Kim SY; Im K; Park SN; Kim JA; Yoon SS; Lee DS
    Leuk Res; 2016 May; 44():45-52. PubMed ID: 27015231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AL amyloidosis in Argentina: hospital Italiano de Buenos Aires.
    Nucifora EM; Aguirre MA; Sorroche P; Saez MS; Fantl D; Rocca JA; Perez de Arenaza D; Varela CF; Greloni G; García Rivello H; Basquiera AL; Alberbide JA; Giunta DH; Boietti BR; Posadas Martínez ML
    Amyloid; 2019; 26(sup1):99-100. PubMed ID: 31343332
    [No Abstract]   [Full Text] [Related]  

  • 9. Molecular cytogenetic aberrations in patients with multiple myeloma studied by interphase fluorescence in situ hybridization.
    Chen L; Li J; Xu W; Qiu H; Zhu Y; Zhang Y; Duan L; Qian S; Lu H
    Exp Oncol; 2007 Jun; 29(2):116-20. PubMed ID: 17704743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Application of CD138 Immunomagnetic Sorting Myeloma Cells Combined with Fluorescence in Situ Hybridization for Detecting Cytogenetic Abnormalities of Multiple Myeloma].
    Gao L; Liu Q; Shi Y; Dang H; He Q; Wang Z; Feng L; Li Y; Wang XY; Li N; Song WJ; Wang YL; Kong S; Lu J; Huang XJ; Lai YY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Jun; 25(3):807-812. PubMed ID: 28641640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Once AL amyloidosis: not always AL amyloidosis.
    Jhaveri T; Sarosiek S; Ruberg FL; Siddiqi O; Berk JL; Sanchorawala V
    Amyloid; 2018 Jun; 25(2):139-140. PubMed ID: 29516761
    [No Abstract]   [Full Text] [Related]  

  • 12. Outcome of Patients With Newly Diagnosed Systemic Light-Chain Amyloidosis Associated With Deletion of 17p.
    Wong SW; Hegenbart U; Palladini G; Shah GL; Landau HJ; Warner M; Toskic D; Jaccard A; Hansen T; Bladé J; Cibeira MT; Kastritis E; Dispenzieri A; Wechalekar A; Varga C; Schönland SO; Comenzo RL
    Clin Lymphoma Myeloma Leuk; 2018 Nov; 18(11):e493-e499. PubMed ID: 30104177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel recurrent chromosomal aberrations detected in clonal plasma cells of light chain amyloidosis patients show potential adverse prognostic effect: first results from a genome-wide copy number array analysis.
    Granzow M; Hegenbart U; Hinderhofer K; Hose D; Seckinger A; Bochtler T; Hemminki K; Goldschmidt H; Schönland SO; Jauch A
    Haematologica; 2017 Jul; 102(7):1281-1290. PubMed ID: 28341732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Magnetic-activated cell sorting combined with multiplex ligation-dependent probe amplification for detecting molecular cytogenetic abnormalities in multiple myeloma].
    Lei M; Ma L; Kuang L; Pang Y; Wu J; Xiao Z; Li L
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Sep; 32(9):1332-5. PubMed ID: 22985577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Detection of Molecular Cytogenetic Aberrations by Fluorescence in Situ Hybridization in Different Bone Marrow Samples of Multiple Myeloma].
    Wang YF; Wang H; Xi LY; Liu Y; Dong F; Wang JJ; Ke XY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Oct; 23(5):1352-6. PubMed ID: 26524036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytogenetic intraclonal heterogeneity of plasma cell dyscrasia in AL amyloidosis as compared with multiple myeloma.
    Bochtler T; Merz M; Hielscher T; Granzow M; Hoffmann K; Krämer A; Raab MS; Hillengass J; Seckinger A; Kimmich C; Dittrich T; Müller-Tidow C; Hose D; Goldschmidt H; Hegenbart U; Jauch A; Schönland SO
    Blood Adv; 2018 Oct; 2(20):2607-2618. PubMed ID: 30327369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and clinical implications of t(11;14) in patients with amyloid light-chain amyloidosis with or without concurrent multiple myeloma.
    Kobayashi H; Abe Y; Miura D; Narita K; Kitadate A; Takeuchi M; Matsue K
    Jpn J Clin Oncol; 2019 Feb; 49(2):195-198. PubMed ID: 30608548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AL amyloidosis diagnosed using anti-IGLL5 antibody: a case report.
    Hiroi T; Mushino T; Tanaka K; Furuya Y; Hori Y; Oiwa T; Kobata H; Yamashita Y; Hosoi H; Murata S; Nishikawa A; Tamura S; Takeuchi S; Nohgawa M; Yamashita T; Ando Y; Hata H; Sonoki T
    Amyloid; 2019; 26(sup1):111-112. PubMed ID: 31343322
    [No Abstract]   [Full Text] [Related]  

  • 19. [Influence of immunomagnetic sorting on detecting genetic aberration of multiple myeloma cells by interphase fluorescence in situ hybridization].
    An G; Li CW; Li Q; Yi SH; Liu XP; Xu Y; Li ZJ; Qi JY; Zou DH; Qiu LG
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Feb; 19(1):54-8. PubMed ID: 21362221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of an immune-magnetic cell sorting method for CD138-positive plasma cells in FISH analysis of multiple myeloma.
    Shin SY; Jang S; Park CJ; Chi HS; Lee JH; Lee JH; Lee KH; Suh C; Lim SE; Seo EJ
    Int J Lab Hematol; 2012 Oct; 34(5):541-6. PubMed ID: 22672327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.